oncoquest
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2013 (NCT01976520)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- oncoquest
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02194751 | Phase 2 | Jun 1, 2018 | Cancer Treatment Centers of America, Xeme Biopharma Inc. |
| NCT01976520 | Phase 1 | Oct 1, 2013 | National Cancer Institute (NCI), Northwestern University, Xeme Biopharma Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Xeme Biopharma Inc. | For profit | 2 | 2 | 2 | 2013 |
| Cancer Treatment Centers of America | Academic/Hospital | 1 | 0 | 1 | 2018 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2013 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 2013 |
4 organizations
Page 1 / 1